Medfinder
Back to blog

Updated: February 18, 2026

Fluticasone/Vilanterol Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Fluticasone/Vilanterol Shortage Update: What Patients Need to Know in 2026

Is Fluticasone/Vilanterol (Breo Ellipta) in shortage in 2026? Get the latest update on availability, pricing, and what patients can do right now.

Fluticasone/Vilanterol in 2026: What's Going On With Supply?

If you rely on Fluticasone/Vilanterol — better known as Breo Ellipta — to manage your asthma or COPD, you may have noticed it's been harder to find at times. Maybe your pharmacy was out of stock, or maybe they told you to check back in a few days.

So what's really going on? Is there a shortage? And what can you do about it? Here's what you need to know.

Is Fluticasone/Vilanterol Still in Shortage?

As of early 2026, Fluticasone/Vilanterol is not listed on the FDA's official drug shortage database. That means there is no nationwide, manufacturer-confirmed shortage.

However, that doesn't mean it's easy to find everywhere. Many patients report intermittent stock-outs at their local pharmacies. These aren't caused by a manufacturing halt — they're typically the result of:

  • Seasonal demand increases during respiratory illness season
  • Regional distribution bottlenecks
  • Insurance formulary shifts that change demand patterns
  • Pharmacy stocking decisions based on local demand

In other words, the medication is being made, but it doesn't always make it to the right pharmacies at the right time.

Why Is Fluticasone/Vilanterol Hard to Find?

Several factors contribute to the difficulty of finding Breo Ellipta at your local pharmacy:

Seasonal Demand

Respiratory medications see the highest demand during fall and winter when flu, colds, and respiratory infections peak. Patients with asthma and COPD are more likely to have flare-ups during these months, driving up prescription fills across the board.

Supply Chain Complexity

Breo Ellipta is manufactured by GlaxoSmithKline (GSK) and distributed through a network of wholesalers. Even when production is steady, delays at any point in the distribution chain — from manufacturing to wholesaler to pharmacy — can create temporary gaps in availability.

Pharmacy Stocking Patterns

Not every pharmacy keeps Breo Ellipta on the shelf. It's an expensive inhaler (around $350 to $450 for the brand without insurance), so some pharmacies only order it when a patient requests it. This means if you're at a new pharmacy or one that doesn't have regular Breo patients, it may not be in stock.

For a deeper dive into why this happens, read our post: Why Is Fluticasone/Vilanterol So Hard to Find?

How Much Does Fluticasone/Vilanterol Cost in 2026?

Cost is a big part of the availability picture. Here's what you can expect to pay:

  • Brand name (Breo Ellipta): $350 to $450 per 30-dose inhaler without insurance
  • Authorized generic: $250 to $350 per 30-dose inhaler without insurance
  • With insurance: Typical copays range from $30 to $75, depending on your plan and tier
  • With GSK savings card: Eligible commercially insured patients may pay as little as $10

If cost is a barrier, check out our complete guide: How to Save Money on Fluticasone/Vilanterol in 2026.

Are There New Options in 2026?

The ICS/LABA inhaler market continues to evolve. Here's what's relevant for Fluticasone/Vilanterol patients in 2026:

  • Authorized generic Breo Ellipta — Available since 2019, this is the same drug in the same device at a lower price. If your pharmacy is out of the brand, ask about the generic.
  • Alternative ICS/LABA inhalers — Symbicort, Advair (with generic options like Wixela Inhub), and Dulera remain widely available alternatives. See our full comparison: Alternatives to Fluticasone/Vilanterol.
  • Triple therapy options — For COPD patients who need more than an ICS/LABA, triple therapy inhalers like Breztri Aerosphere and Trelegy Ellipta (which also uses the Ellipta device) combine three medications in one inhaler.

How to Find Fluticasone/Vilanterol in Stock

If your pharmacy doesn't have it, here's what to do:

  1. Use Medfinder to search for pharmacies near you that have it in stock right now.
  2. Try independent pharmacies — They often have better flexibility in sourcing medications from multiple wholesalers.
  3. Ask about the generic — Your pharmacy may have the authorized generic even if the brand name is unavailable.
  4. Consider mail-order — Your insurance plan's mail-order pharmacy may have better stock for maintenance medications.
  5. Call ahead — Save yourself a trip by calling the pharmacy first. For more tips, see how to check if a pharmacy has Fluticasone/Vilanterol in stock.

Final Thoughts

While there's no official shortage of Fluticasone/Vilanterol in 2026, finding it can still be a challenge depending on where you live and which pharmacy you use. The supply exists — it's just not always where you need it, when you need it.

Stay proactive: refill early, use Medfinder to check availability, and talk to your doctor if you're consistently having trouble. Your breathing is too important to leave to chance.

Frequently Asked Questions

No. As of early 2026, Fluticasone/Vilanterol (Breo Ellipta) is not listed on the FDA's drug shortage database. However, some pharmacies experience temporary stock-outs due to seasonal demand, distribution delays, and local stocking decisions.

The brand-name Breo Ellipta costs approximately $350 to $450 per 30-dose inhaler without insurance. The authorized generic version costs around $250 to $350. With a GSK savings card, commercially insured patients may pay as little as $10.

Yes. An authorized generic version of Fluticasone/Vilanterol in the Ellipta inhaler device has been available since 2019. It contains the same active ingredients and typically costs $100 to $150 less than the brand-name version.

Use Medfinder to search nearby pharmacies, try independent or specialty pharmacies, ask about the authorized generic, consider mail-order pharmacy through your insurance, and talk to your doctor about alternative ICS/LABA inhalers like Symbicort or Advair if needed.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Fluticasone also looked for:

32,326 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,326 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?